---
document_datetime: 2023-09-21 19:16:43
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/wilzin-epar-all-authorised-presentations_en.pdf
document_name: wilzin-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.8339433
conversion_datetime: 2025-12-14 21:41:59.247914
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name Name   | Strength    | Pharmaceutical Form       | Route of administration   | Packaging     | Package size   |
|-----------------|----------------------|-------------|---------------------------|---------------------------|---------------|----------------|
| EU/1/04/286/001 | Wilzin               | 25 mg 50 mg | Hard capsule Hard capsule | Oral use Oral use         | Bottle (HDPE) | 250 capsules   |
| EU/1/04/286/002 | Wilzin               |             |                           |                           | Bottle (HDPE) | 250 capsules   |